
CytoMed Therapeutics Limited
GDTCHealthcare|Biotechnology|SG
$0.86
-0.02 (-2.39%)
DCF Value
$1.16
Tangible Book / Share
$0.45
Cash / Share
$0.12
Ownership Breakdown
29.8%
Float
11.8M
Shares Outstanding
3.5M
Float Shares
Major Holders (3)
Combined: 42.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (24)
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Choo Chee Kong | director, 10 percent owner: | Jul 20, 2026 | BUY | 100,000 | $1.50 | $150.0K | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Jul 14, 2026 | BUY | 100,000 | $1.50 | $150.0K | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Jul 20, 2026 | BUY | 100,000 | $1.50 | $150.0K | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Jul 14, 2026 | BUY | 100,000 | $1.50 | $150.0K | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | May 13, 2026 | BUY | 112,000 | $1.15 | $128.8K | Form 4 |
| Toh Keng Kiat | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Yew Chak Hua | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Leong Mark Kei Wei | director: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| TAN YOONG YING | Chief Corporate Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Goh Yvonne | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Loh Yuin Han | director: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Leong Mark Kei Wei | director: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Zeng Jieming | director, officer: CSO and CMO | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Toh Keng Kiat | director: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Choo Chee Kong | director, 10 percent owner: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Luk Lucas Tien Wee | director, officer: Chief Clinical Officer | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Yew Chak Hua | director: | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Tan Wee Kiat | director, officer: Chief Operating Officer | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Wang Shu | 10 percent owner | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |
| Glorious Finance Ltd | 10 percent owner | Mar 31, 2023 | OTHER | 0 | — | — | Form 4 |